Big Promise Of A 10x

SPEAKER_00 0:00

Every 10 bagger that Hugh and I have ever studied, think Tesla, Netflix, Nvidia, Amazon, they all did this exact same thing before they exploded, just like Hugh's about to. And right now, there is one stock that is doing the exact same thing that almost nobody is talking about. By the end of this video, you'll understand the one pattern. Every 10x stock shares before it moves. And this specific company, I believe, has a legitimate shot at being the firm monster of the year, a 10x stock by 2030. If you're wondering who I am, that was Hugh who does our research. My name is Felix Prinum, an ex-investment banker. I'm also the founder of the Goat Academy, where my retired Wall Street mentors have been teaching regular investors the institutional strategies for the last six years. We've taught well over 20,000 people so far. And I'm not going to lie to you, this video is going to be a little bit information dense. So to make sure it really lands for you, you get the value out of it that I want you to get, I'm going to give you a bonusful research report on everything that I'm covering today, plus more, because videos have a time limit, and Hugh, of course, wrote it. So you can download it for free at FelixFriends.org slash ADPT. And ADPT is the stock ticker we're talking about here. So if you're one of those people who comes for a stock tip and then complains about it three months later, now you have the ticker. If you're the kind of person who wants to learn how to fish rather than get a three-day old slightly smelly fish, stick around.

S&P 500 Concentration Shock

SPEAKER_00 1:38

Now before we dive into the 10x pick, I need to show you something that might change how you think about your portfolio. Because most people watching this have their retirement savings in an index fund, right? The SP 500. I know you own some index funds of the SP 500. Even if you think you don't, well, you probably do in your 401k or whatever retirement fund you have. And it's nice and safe, right? Sort of set it and forget it, right? Well, what if I told you that that safe fund is hiding a secret that could cost you a fortune? Your SP 500 index fund is cheating on you. It has a mistress. Because you see, it's 500 companies, right? Which sounds kind of diversified. But right now, just 10 stocks, just 10 stocks are responsible for 72% of all your gains. Maybe you don't believe me or not. I'll show you the actual chart here in the Winston app, because I just added it to the Winston app so you can see the stuff in track. It will update this for you every week. Now, it actually just jumped from 72% to 59% today. And that is because we're selling off the winners. A handful of tech giants, basically, they're wearing a trench coat pretending to be a diversified fund. So if you think you own the US economy, you actually own a tech bet on 10 companies. And what happens when the tech stocks have a bad week or quarter, while your diversified retirement fund drops massively because it was never really diversified at all. And literally this number yesterday was 72%, right now it's only 59%.

Share Dilution And The Pizza Treatment

SPEAKER_00 3:20

And it gets worse. Those very tech stocks are about to dilute the heck out of you. Alphabet, the company that owns Google, just announced they're printing $80 billion worth of new stock. And yeah, you can do that when you're a listed company. $80 billion. Meta, Facebook's parent, is planning something very similar. Now, what happens when a company prints new shares? Think of it like a pizza. You and your friends order the pizza, and you own two slices of that pizza. Life's good. You got two slices. Then the restaurant comes back and says, actually, we cut the pizza into twice as many slices. You still have two slices, but the pizza is the same size. So your slices just got thinner. Same pizza, less for you. And that's exactly what's happening to your index fund right now. I call it the pizza treatment. The biggest companies in the world are printing new slices, and your slices are getting thinner and thinner and thinner, which is fine if you're on a Zenpik. Otherwise, you're like, where the heck's my pizza? You didn't ask for it, you didn't choose it, but you're paying the same price for it. And one of the most legendary investors out there, best friend of Charlie Munger all his life, just warned of the SP right now is twice as expensive as it is on average. And that it is more expensive than it was in 2000. And I don't have to tell you what happens after 2000. So the unpopular truth is you're sitting there holding what you think is a safe, boring buy and hold forever kind of an index fund. But really, it is a concentrated bet on these 10 tech companies at double the normal valuation. And those companies are actively printing shares and making yours worth less, and you have no say in it. But some people will get very wealthy over the next years. They'll see the rotation, they'll see the money moving, and they'll position themselves ahead of all the others. And the rest, well, the rest will find out in 10 years that their safe fund barely kept gap with inflation, and that the money they thought was growing was quietly being eaten alive, and by then it'll be too late. Wall Street already knows this. The big institutions already are repositioning. So the question is, do you have that plan? And

Free Live Index Trap Seminar

SPEAKER_00 5:46

I appreciate that's gonna sound unsettling for many of you. And that's exactly why I'm running a seminar for beginner investors for the first time ever this weekend, live from France. Uh, it is called the Index Fund Trep, uh, why the SP 500 is lying to you, uh, like a mistress. And I want to be real with you, in all seriousness. First time I've ever done this, first time I've ever run the seminar. I've never taught this material live before. And honestly, I might never do it again because it's a later work. So I'm doing this because of what's happening right now on the market. I think it demands it. And what I'm gonna show you is the specific playbook, the concentration trap, the dilution, the rotation that's already happening, and exactly how to react to it, how to position yourself so you're on the right side of it. And if you don't learn this now, I think you're gonna find out the hard way in five years, ten years, when your retirement account tells the story. And by then, you might be like, oh, I wish I would have shown up that Saturday. Um free. One time only, there'll be no replay, don't ask me for one. So you've got a single dollar in an index fund, you need to be there. Get your free seat at indextrap.com. Anybody else you know, you should also be there. Send them that link, indextrap.com. The more people we reach, the bigger the impact we can make here in a positive way. But there is good news. You don't have to sit in a concentrated, overpriced index fund and hope for the best. There is a way to find the stocks that might outperform before they move, before the crowd catches on.

The Sideways Spring Behind 10x Stocks

SPEAKER_00 7:28

And it starts with one pattern that every massive winner in the stock market history has in common. So let me show you that. Now, of course, this isn't financial advice. I'm not a registered financial advisor. I'm not telling you to buy this stock, couldn't care less whether you do. I'm teaching you the principle, I'm teaching you the rules, I'm teaching you how to fish. I'm not handing you a fish that's gonna go smelly and rotten in three days if the cats don't eat it. You don't let leaf food out with hue around, I can tell you that much. The one thing every 10 bagger has in common. What do you think that is? Put it in the comments down below. Seriously, put it in the comments down below. Just pause for a second, put in the comments down below, don't cheat. What do Tesla, Netflix, and Apple and all these great companies have in common? Besides making people very, very rich. Before any of them exploded, they ordered something that scared everybody away. Did what? The stock chart did this for a very, very, very long time. It went sideways for years. I'm talking, literally, we've done the research, two to four years. Stock just sat there doing nada, flatlining like a heart monitor. And during those boring, painful years, most people gave up on the stock. They sold, they moved on, they said this stock's dead. And then, bingo. Why does it work? Think of it like a spring. Imagine you're pushing a spring down onto a table, you push it down for a month, it'll bounce back a little. You push it down for a year really, really, really hard, it'll bounce back more. You push it down for four years. When you finally let go, that thing flies to the ceiling. And that's what's happening when a stock goes sideways for years. The spring is being compressed, the business is growing underneath, more customers, more revenue, more profit, but the stock price isn't reflecting any of that. And at some point, the market has to catch up. And when it does, it's your 10x possibility. Let me show you a real example here. Tesla. Between 2017, somewhere here, and 2020, it basically traded like a boring little thing, just going sideways, right? Absolutely baggage all happening there on that stock trap, just doing nothing, absolutely nothing. And the headlines were like Tesla's going bankrupt. Elon is crazy. This company is done. But underneath it, they were building gigafactories, they were ramping up Model 3 production, they were growing revenue. And then in 2020, the spring released, and the stock went up 10 10, 10x, 17x, whatever. If you look at you look at Netflix, in 2011, Netflix crashed 80%. Everybody said streaming is a fad. And then nothing happened in 2012. Nothing at all, nothing at all, nothing at all. 2013 came around, and boom, this thing has been going up and up and up and up and up and up and up and up. You know, way, way, way, way past the 10x because they were adding 2 million streaming subscribers every quarter. And look at Apple. 2015 to 2018, basically nothing happened at all. Four years, Apple stock traded basically the same price. And people thought Apple has done growing. But the iPhone installed base was exploding. Service revenue was compounding, and the company was buying back billions of its own shares, blood stock to really, really, really start going up 90% that year alone. And it doubled again and again. So what did we look for? Here's the three-step checklist.

Three Step Checklist For Breakouts

SPEAKER_00 11:05

When I find a stock that's been going sideways for a very long time, and here's the stock chart of ADPT, it's trading at 2022 valuations. It's done nothing in 2022, nothing in 2023, nothing in 2024, nothing in 2025. I asked some questions. Is the business growing while the stock is flat? Are institutions quietly accumulating? Unless they're a catalyst approaching. I'm looking for a disconnect. I'm looking for volume to slowly increase down here. Nothing major, just a slow increase. So I can see the smart money on the green days is buying, and on the big red days, the guys who wanted to get out of this are finally out of this until finally these red candles get smaller. Write these down if you haven't already. And there is a stock doing this right now, in my humble opinion. Don't run out and buy it. You're going to come to your own conclusion. And it's a stock that could literally save your life. Like ADPT, a company called Adaptive Biotech Technologies. Now I've got it open here in uh in the Winston app. It's got a terrible score, right? Terrible score. We score out of 100. See, the score is improving a little, but not a lot, over the last year or so. But it's growing, right? It's actually growing quite impressively. And what it's all about is this. And by the way, if you want to play around with the Winston app, we literally are given in a way. There's a whole three-month trial to it. So for a whole month, you're going to get access to it for free. If you don't like it, just cancel on day 29. Links down below in the description. But in all

ADPT And The Cancer Smoke Detector

SPEAKER_00 12:35

seriousness, every three minutes in America, someone's diagnosed with blood cancer, leukemia, lymphoma, all that stuff. And they're literally 1.7 million Americans right now living with or in remission from a blood cancer. Now imagine you're one of those people. You've just gone through months of chemotherapy, your hair fell out, you couldn't eat, you could barely get out of bed, and finally your doctor looks at you and says, The treatment's worked. You think we caught it up? You think, or you know. That's literally the scariest question in medicine, right? Because even a tiny amount of cancer, if it's still hiding in your body, invisible to a normal blood test, invisible to a scan, it can come back. And that is where this company comes in. And by the way, there is never any sponsorship on this channel, right? I never take any money from this, any any company ever, never will, no endorsements of any kind. I also don't own the stock. So I just want to be very clear with that. I might own the stock at some point in the future, I might buy it, and I might sell it, and I might not tell you about it because I don't make a video every single day on every stock I buy. But what this company does in a simple way is they make a test called clono SEQ. And what it does is every cancer has sort of a unique fingerprint. Think of it like a barcode. Like the barcode on a product of a grocery store, right? They read your blood and they look for that specific barcode. And it is so sensitive, it can find one single cancer cell hiding among one million healthy cells, one annoying. It's like finding one specific person in the entire city of, I don't know, Dallas or something by their fingerprint alone. So it's like a smoke detector for cancer. And a regular checkup is like walking through your house looking for flames, right? Teeny tiny flames. If you see fire, it's bad. So clono SEQ is the smoke detector before the fire starts. It catches the wisp of smoke before there is ever a fire, before the cancer comes back, before it spreads. And that early warning changes everything. Your doctor can adjust your treatment before it returns instead of waiting until it's too late. And what makes this interesting as an investment thesis?

Why Profitability Could Wake Markets

SPEAKER_00 14:54

And this, of course, is a high-risk investment thesis, like all investments, but biotech particularly is. Nobody else has it. There are over 250 medical studies that back it up. More than half of all blood cancer doctors in America already use it. And there are over 160 drug companies that are using it in their clinical trials to test whether their new cancer drugs actually work. Insurance covers it for over 300 million Americans. So most patients can get it without paying for it. But the punchline is this they're still at less than 15% penetration in most of the cancers it treats. Think about that. The only FDA clear test, half of doctors are already on board, insurance companies cover it, and 85% of the opportunity is still ahead of them. Remember our framework, stay one, is the business growing while the stock is flat. Well, going to the Winston up, revenue growth, right? It's been growing pretty impressively. 35% last quarter, 51% the quarter before, 102% the quarter before that. And it's been growing for like four years straight. That's the spring compressor. What we saw in Tesla and in Netflix and so on. And they're forecasting about 270 million in revenue. Total market is about 6 billion. So they're doing about 5% of the total addressable pie. So what's the catalyst? Something that forces the market to look at this and go, this is actually worth more than this trading at right. Well, this year, for the first time ever, this company is expected to become profitable. They've never made money before. Like most of these bioctech companies don't make money for years. Now they probably will. And when a company flips from losing money to making money, the market tends to wake up for it. It's like the switch gets flipped, right? The stock goes from being ignored to being, well, it's on every screen because a lot of investors, a lot of pension funds, they want to invest in profitable companies. It's easier to justify, it's easier to understand. So let me tell you why the 10X, in my humble opinion, isn't a fantasy. Doesn't mean it's going to happen. I haven't got a crystal ball. It doesn't mean there isn't high risk in you losing your money. So position size accordingly and obviously decide for your own whether this is something you want to be exposed to. Definitely not the sort of thing you want to put all your money into. The whole company right now, it's worth about 2.7 billion here, market cap, right? I've got it on the slide here too, but it's 2.7 billion. The total market they can go after is 6 billion. So if they capture, say, a quarter of that, I'm not saying they're going to get everything. Say they get a billion and a half in revenue. And at the moment they're the only FDA cleared player, so why wouldn't they? You get fast growth, you get very good margins, you get a moat. There should be a premium for the way this is valued, right? Now, should's always a dangerous word. We've had a four-year

Biotech Risk And Position Sizing

SPEAKER_00 17:44

base. It peaked in 2021. It crashed really, really, really hard. Let me show you the chart here. Also, give you a little bit of an idea of just how risky biotech investing really is if you haven't got rules. This thing from the very top is down 87% right now. This is not something you buy and hold till the end of time. No. But since 2022, we've done nothing. So if we were to go back up to where we once were, and again, I'm not promising you that, that in itself would be, you know, why were they trading that high during the pandemic? You know, lots of testing going on there. So there is risk, right? It is a small company. There is therefore more risk. There is competition. There's a company called Natira. We're expanding into blood cancers. There'll be competition. There always is. And they have to execute. Nothing is guaranteed. Management might lose their marbles. So this is not a buy recommendation. You've got to do your own homework. But it's the sort of thing that I look at and I go, that's very interesting. But it's only interesting when you understand the framework, you understand the base, you understand the revenue growth, you understand the catalyst. So to me, I love stocks that do nothing for years. I don't want to own them where they do nothing for years. But when they start breaking out of that, that's when I'm interested to actually own them.

Final Warning And How To Join

SPEAKER_00 18:59

And most importantly, the message I want to get across to you is that if you're still an index fund investor and you don't have a plan for what's coming, join me live this weekend. First time I've ever taught this publicly. I might never do it again. It's free. It's live. So if you're relying on the SP 500 for your retirement, this is the most important two hours you're going to spend this year. Go to indextrap.com, grab yourself a free seat before it fills up. Sharp on time. There'll be no replay. And I'll see you there. Share it with people who might benefit from this too. And if this has been helpful for you, share the video, share the link to indextrap.com with people who might benefit from it. And I wish you tremendous success.